MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 53 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,353 | -7.1% | 46,538 | +59.4% | 0.00% | – |
Q1 2024 | $7,913 | -8.2% | 29,199 | -26.8% | 0.00% | – |
Q4 2023 | $8,621 | +41.9% | 39,913 | -14.6% | 0.00% | – |
Q3 2023 | $6,074 | +111.0% | 46,722 | +484.4% | 0.00% | – |
Q2 2023 | $2,878 | +28680.0% | 7,995 | -62.4% | 0.00% | – |
Q1 2023 | $10 | +25.0% | 21,255 | +31.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 16,231 | -16.1% | 0.00% | – |
Q3 2022 | $12,000 | +140.0% | 19,349 | +245.1% | 0.00% | – |
Q1 2022 | $5,000 | -91.7% | 5,607 | -87.8% | 0.00% | -100.0% |
Q3 2021 | $60,000 | -27.7% | 45,936 | -41.9% | 0.00% | +100.0% |
Q1 2021 | $83,000 | +730.0% | 79,023 | +965.9% | 0.00% | – |
Q4 2020 | $10,000 | – | 7,414 | +7314.0% | 0.00% | – |
Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 100 | -98.2% | 0.00% | – |
Q2 2018 | $2,000 | -92.0% | 5,529 | -73.9% | 0.00% | -100.0% |
Q4 2017 | $25,000 | – | 21,181 | +264662.5% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 8 | -99.9% | 0.00% | -100.0% |
Q2 2017 | $22,000 | – | 13,260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |